Business

Microbiome Sequencing Services Market Size Analysis and Regional Analysis Forecast to 2024-2032

Mr Accuracyreports has published a new research report titled “

Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing), By Laboratory Type (Wet, Dry), By Research Type (Outsourced, Internal), By Application (Shotgun Sequencing, Targeted Gene Sequencing, RNA Sequencing,

” in its research database. Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs –

https://www.mraccuracyreports.com/marketreports/5/856608/Microbiome-Sequencing-Services-Market

https://www.mraccuracyreports.com/request/download/5/856608/Microbiome-Sequencing-Services-Market

Microbiome Sequencing Services Market Valuation – 2024-2031

The growing need for personalized medicine, advancements in sequencing technologies, and a greater comprehension of the microbiome’s role in human health and disease are driving the market for microbiome sequencing services. According to the analyst from Market Research, the Microbiome Sequencing Services Market is estimated to reach a valuation of USD 4 Billion over the forecast period 2031, subjugating around USD 1.63 Billion valued in 2023.

A growing understanding of the role of the microbiome in disease prevention, diagnosis, and treatment and the growth of academic-biotech partnerships, are further factors driving the market. It enables the market to grow at a CAGR of 11.87% from 2024 to 2031.

Microbiome Sequencing Services Market: Definition/Overview

Microbiome sequencing services are the process of detecting and analyzing the genetic material of microorganisms found in a specific environment, such as the human body or soil, using high-throughput sequencing technologies. This service gives precise insights into the structure and function of microbial communities, allowing for a better understanding of their roles in health and illness.

Furthermore, microbiome sequencing has a wide range of applications, including healthcare, where it is used to examine the impact of the microbiome on disorders such as inflammatory bowel disease, obesity, and diabetes, ultimately leading to personalized medication. It also plays an important role in agricultural research, analyzing soil microbiomes to increase crop productivity, and in environmental science, assessing microbial diversity and function in various ecosystems.

What’s inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Advancements in High-throughput Sequencing Technologies Influence the growth of the Microbiome Sequencing Services Market?

Rapid improvements in high-throughput sequencing technologies, including Next-Generation Sequencing (NGS), have reduced the cost of microbial genome sequencing while increasing its speed and accuracy. This technical advancement has made microbiome sequencing more accessible and possible for a variety of academic and therapeutic applications, resulting in increased demand for these services.

Microbiome sequencing has applications beyond human health, such as agriculture, environmental science, and pharmaceuticals. In healthcare, microbiome sequencing is used to produce personalized medicine, improve diagnostic methods, and create novel therapeutic tactics. In agriculture, it aids in improving soil health, crop output, and understanding plant-microbe interactions. This growing number of applications in many sectors has fueled the expansion of the Microbiome Sequencing Services Market.

Furthermore, there is a rising interest in examining the human microbiome and its role in health and disease. Research in this field has helped us understand the function of the microbiome in a variety of disorders, including obesity, diabetes, autoimmune diseases, and even mental health difficulties. This increased emphasis on microbiome research has resulted in a surge in demand for sequencing services to precisely analyze microbial communities.

How will Need for Highly Skilled Professionals Favor Microbiome Sequencing Services Market?

The complexity of analyzing and interpreting the enormous volumes of data generated is one of the major obstacles to the Microbiome Sequencing Services Market. Data analysis is especially difficult due to the diversity of microbial populations and their interactions in various settings or hosts. This complexity demands sophisticated bioinformatics tools and experience, which creates an obstacle for researchers and enterprises without in-house capabilities or access to modern analytical platforms, limiting the market’s expansion.

Microbiome research lacks standardized procedures for sample collection, DNA extraction, sequencing protocols, and data processing. This unpredictability makes it difficult to reproduce and compare results across studies and providers. The lack of globally acknowledged standards and methodologies makes it challenging to evaluate and compare findings, proving crucial for furthering research and developing microbiome-based applications and inhibiting commercial adoption.

Category-wise Acumens

How Does the Dominance of the Sequencing by Synthesis (SBS) Technology Impact the Market?

According to analyst, the sequencing by synthesis (SBS) segment is expected to dominate the segment within the Microbiome Sequencing Services Market. SBS technology, as represented by Next-Generation Sequencing (NGS) platforms such as Illumina’s sequencing systems, has high-throughput capabilities, allowing for the simultaneous sequencing of millions of DNA molecules. This efficiency is critical for microbiome sequencing, which involves analyzing complex and diverse microbial communities. This capacity to process huge volumes of samples rapidly and efficiently is a key reason for SBS’s dominant position in the market.

SBS technology ensures excellent precision and reliability in sequencing findings. It has a lower error rate than other sequencing technologies, which is important when identifying and measuring microbial species in a community. The great quality of SBS technology allows researchers and physicians to make educated judgements based on accurate and dependable data, contributing to its widespread adoption.

Furthermore, although the initial investment in SBS technology can be large, the per-sample cost of sequencing has dramatically lowered over the years as SBS technology has advanced and the market has become more competitive. This cost reduction has made SBS more accessible to a wider group of researchers and institutions, allowing for more comprehensive and diverse microbiome research programmes. SBS’s low cost, combined with its high throughput and accuracy, make it an appealing choice for microbiome sequencing services.

How Does Access to Advanced Technologies Contribute to the Dominance of Outsourced Segment?

The outsourced segment is estimated to hold the largest share of the Microbiome Sequencing Services Market during the forecast period. Outsourcing microbiome sequencing enables research organizations and businesses to leverage cutting-edge sequencing technologies and bioinformatics tools without incurring significant equipment and training costs. Service providers specialize in sequencing and have the experience and infrastructure to manage complicated projects, which can dramatically enhance sequencing quality and speed. This access is especially useful for small and medium-sized businesses and academic institutions that may lack the means to operate cutting-edge sequencing facilities in-house.

Furthermore, outsourced microbiome sequencing services provide greater flexibility and scalability than internal capabilities. Service providers can readily scale their operations up or down to meet the demands and specific needs of their clients, accommodating everything from tiny exploratory investigations to large-scale sequencing initiatives. This scalability enables research organizations to respond swiftly to changing project scopes and research goals, rather than being constrained by the capacity of their internal facilities.

Gain Access to Microbiome Sequencing Services Market Report Methodology

Country/Region-wise Acumens

How will Demand for Microbiome Sequencing Services in North America Influence the Market?

According to Analysis, the North American region is estimated to dominate in Microbiome Sequencing Services Market during the forecast period. North America is at the forefront of implementing advanced technology, such as next-generation sequencing (NGS), which is essential for microbiome sequencing. The region’s openness to incorporate new technology into research and clinical practices improves its ability to perform large-scale microbiome studies, increasing in demand for sequencing services. The existence of leading sequencing technology businesses and startups in North America reinforces this trend.

Furthermore, in North America, there is a rising recognition of the microbiome’s significance in health, illness, and environmental applications. This understanding is evident in the increased use of microbiome sequencing in a variety of disciplines, including healthcare, pharmaceuticals, agriculture, and environmental science. For example, in healthcare, there is a considerable emphasis on creating microbiome-based diagnostics, treatments, and personalized medicine. This broad application scope promotes demand for microbiome sequencing services, supporting regional market growth.

Will the Asia Pacific Propel the Demand for Microbiome Sequencing Services?

Asia Pacific is expected to grow at the highest CAGR in the Microbiome Sequencing Services Market during the forecast period. Countries in the Asia Pacific region, particularly China, Japan, South Korea, and Australia, are investing heavily in biotechnology R&D. This includes funding for the development of research infrastructure, including cutting-edge laboratories and sequencing facilities, as well as support for biotech firms and academic microbiome research programs. These investments are laying a solid platform for microbiome research and sequencing services, hence boosting market expansion.

Furthermore, the importance of the microbiome in human health, nutrition, and illness is becoming more widely recognized in Asia Pacific. This increased awareness is generating interest and research in fields such as probiotics, personalized medicine, and microbiome-based therapeutics. The rising prevalence of chronic diseases in the region, which may be connected to microbial imbalances is driving research activities and demand for sequencing services to better understand and treat these conditions.

Competitive Landscape

The competitive landscape of the Microbiome Sequencing Services Market is marked by fierce competition among firms seeking to develop and broaden their offerings. Partnerships, collaborations, and acquisitions are also frequent tactics used by businesses to boost their market position, broaden their geographic reach, and improve their service offering.

Some of the prominent players operating in the Microbiome Sequencing Services Market include:

Charles River Laboratories, Eurofins Scientific, BGI, CosmosID, Microba, QIAGEN, Microbiome Insights, BaseClear, CD Genomics, Zymo Research, OraSure Technologies, MR DNA, Eremid Genomic Services, Clinical-Microbiomics A/S, Novogene Co., EzBiome, Boster Biological Technology, Zifo, Macrogen.

Latest Developments:

  • In May 2023, CosmosID presented new findings on the gut microbiome and its relationship with chronic inflammatory disorders at the American Gastroenterological Association (AGA) meeting.
  • In February 2023, Charles River Laboratories announced a collaboration with Danone Nutricia Research to create a microbiome research centre focusing on early-life nutrition and gut health.
  • In January 2024, Eurofins Scientific acquired LabWest, an Australian contract research organization (CRO), boosting its service offerings in Asia-Pacific, including microbiome testing.
  • In December 2023, BGI announced its new metagenomics sequencing tool, MGseq-1000, which provides researchers with a faster and more cost-effective choice for microbiome investigation.

Report Scope

REPORT ATTRIBUTES DETAILS
Study Period

2018-2031

Growth Rate

CAGR of ~11.87% from 2024 to 2031

Base Year for Valuation

2023

Historical Period

2018-2022

Forecast Period

2024-2031

Quantitative Units

Value in USD Billion

Report Coverage

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

Segments Covered
  • By Technology
  • By Laboratory Type
  • By Research Type
  • By Application
  • By End-User
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players
  • Charles River Laboratories
  • Eurofins Scientific
  • BGI
  • CosmosID
  • Microba
  • QIAGEN
  • Microbiome Insights
  • BaseClear
  • CD Genomics
  • Zymo Research
  • OraSure Technologies
  • MR DNA
  • Eremid Genomic Services
  • Clinical-Microbiomics A/S
  • Novogene Co.
  • EzBiome
  • Boster Biological Technology
  • Zifo
  • Macrogen
Customization

Report customization along with purchase available upon request.

Microbiome Sequencing Services Market, By Category

Technology:

  • Sequencing by Synthesis (SBS)
  • Sequencing by Ligation (SBL)
  • Pyrosequencing
  • Sanger Sequencing
  • Others

Laboratory Type:

  • Wet Labs
  • Dry Labs

Research Type:

  • Outsourced
  • Internal

Application:

  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Others

End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Others

Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Some of the key players leading in the Microbiome Sequencing Services Market include Charles River Laboratories, Eurofins Scientific, BGI, CosmosID, Microba, QIAGEN, Microbiome Insights, BaseClear, and CD Genomics.
The increased desire for personalized medicine is anticipated to drive the growth of Microbiome Sequencing Services Market.
The Microbiome Sequencing Services Market is estimated to grow at a CAGR of 11.87% during the forecast period.